₹ 466.50
-9.50 (-2.00%)
BSE
A
Aptus Pharma
₹ 466.50
BSE
Aptus Pharma Fundamentals
Company Valuation
Market Cap (₹ Cr.)
800
PE Ratio
-
PB Ratio
34.97
Dividend Yield
-
ROE
19.79%
ROCE
29.60%
Book Value (₹)
13.61
Face Value (₹)
10.00
Analyse APPL with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Dec 2025 | Mar 2026 | May 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 72.89% | 72.89% | 72.89% | 72.89% | 72.89% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 22.97% | 23.47% | 23.76% | 24.03% | 24.55% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
APPL Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Consumer Discretionary
Sub Sector
Consumer Durables
Company Classification
SME
BSE Scrip Code
544529
NSE Scrip Name
APPL
ISIN
INE15XJ01010

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






